In the present study, we investigated whether EA treatment could ameliorate cognitive impairment and attenuate Aβ deposits, and the effect of EA treatment on BDNF expression and neurogenesis in the amyloid precursor protein (APP)/presenilin 1 (PS1) double transgenic (Tg) mice. The gene discussed is PSEN1; the disease is Cognitive impairment.